TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected Patients
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This trial is designed to assess the swallowability of uncoated and film-coated 200 mg
etravirine tablets in HIV-1 infected patients. In addition, comparisons between a single 200
mg tablet versus two 100 mg formulations will be made. The outcome of the trial will aid in
making decisions about the future commercial 200 mg formulation.